Allowable Overruns means, for all Research Programs in the aggregate, any FTE Costs or Out-of-Pocket Costs incurred by or on behalf of a Party in any Calendar Year in the performance of Research Activities under each applicable Research Plan for each Research Program that (a) is not attributable to any breach of this Agreement by Morphic and (b) is in excess of the aggregate amount budgeted for such Research Activities across all Research Budgets for such Calendar Year by an amount not to exceed the greater of [***] of the amount budgeted for such activities across all Research Budgets and [***].
Allowable Overruns means any amount that is [***] above the total budgeted or approved amounts for a [***] on a [***] basis set forth in the Co-Funded Development Budget, Co-Funded Commercialization Budget, or Co-Funded Medical Affairs Budget, or Other Operating Expenses Budget for such [***].
Allowable Overruns means any amount that is up to [***] above the total budgeted or approved amounts for a Calendar Year on a quarterly basis set forth in any Shared Expenses Budget for such Calendar Year to the extent such amount is not attributable to a Party’s action or inaction that constitutes a breach or default under this Agreement.
Examples of Allowable Overruns in a sentence
Each Party shall be responsible for its share of Allowable Development Expenses plus Allowable Overruns (collectively, “Reimbursable Development Expenses”) incurred by both Parties in connection with the Development of Licensed Products for use in the Licensed Field in the Territory as set forth in Schedule 3.3. The Development Plan attached hereto as Schedule 3.2.1 includes a detailed Budget for the initial period upon commencement of Development activities pursuant to Section 3.1.1 until [****].
More Definitions of Allowable Overruns
Allowable Overruns means, on a plan-by-plan basis, any amount incurred by a Party in the performance of the activities taken as a whole under a Joint Development Plan, Joint Medical Affairs Plan or Joint Commercialization Plan or with respect to CMC Activities under a Manufacturing Plan, in each case, that is (a) above the applicable amounts budgeted for the performance of such activities taken as a whole under the corresponding Joint Development Budget, Joint Medical Affairs Budget, Joint Commercialization Budget or Manufacturing Budget, as applicable, in each case, by [**] percent ([**]%) or less for such Calendar Year, provided that such amounts were not attributable to a breach of this Agreement by the performing Party; or (b) otherwise approved by the JSC.
Allowable Overruns means any Global Development Costs incurred by or on behalf of a Party or its Affiliates in any Calendar Year that are above the then-current Global Development Budget for such Calendar Year by [***] or less.
Allowable Overruns means, (a) on a Licensed Category 1 Target‑by‑Licensed Category 1 TARGET BASIS, (I) ANY AMOUNT THAT is [***]; or (b) on a Licensed Category 2 Target-by-Licensed Category 2 Target basis, (i) any amount that is [***].
Allowable Overruns means, (a) on a Licensed Category 1 Target‑by‑Licensed Category 1 Target basis, (i) any amount that is [***]; or (b) on a Licensed Category 2 Target-by-Licensed Category 2 Target basis, (i) any amount that is [***].
Allowable Overruns means any and all Development Costs or Medical Affairs Costs, as applicable, incurred by or on behalf of Sarepta or its Affiliates with respect to any Licensed Product in any Calendar Quarter that are (a) above the then-current Joint Global Development Budget or Joint Global Medical Affairs Budget, as applicable, approved by the JSC by [**] or less or (b) otherwise attributable to Roche’s action or inaction that constitutes a breach of this Agreement.
Allowable Overruns means, for Licensed Assets that are Profit-Share Products, on a Licensed Asset-by Licensed Asset basis, any amount that is [***] above the total budgeted or approved amounts for a Calendar Year on a year to date basis set forth in any Co-Funded Development Budget, Co-Funded Commercialization Budget, or Co-Funded Medical Affairs Budget for such Calendar Year for all Profit-Share Products that comprise the same Licensed Asset,[***] for all Profit-Share Products comprising the same Licensed Asset in the applicable budget (i.e., either the Co-Funded Development Budget, Co-Funded Commercialization Budget, or Co-Funded Medical Affairs Budget) for any Calendar Year], provided that, subject to [***] such amount is not incurred as a result of [***].
Allowable Overruns means, for one or more given Research Activities in a given Calendar Year, any FTE Costs or Out-of-Pocket Costs incurred by or on behalf of a given Party in the performance of such Research Activities allocated to such Party under the Research Plan that (a) are not attributable to any breach of this Agreement by such Party and (b) are in excess of the aggregate amount budgeted for such Research Activities in the Research Budget for such Calendar Year (i) by an amount not to exceed [*] of such amount budgeted for such Calendar Year or (ii) otherwise approved by the JSC in accordance with Section 3.2 (Joint Steering Committee). 1.9 “Antitrust Clearance Date” has the meaning set forth in Section 15.1 (Effective Date). 1.10 “Antitrust Laws” means any and all applicable Laws designed to prohibit, restrict or regulate actions for the purpose or effect of monopolization or restraint of trade. 1.11 “BIMA” has the meaning set forth in the preamble. 1.12 “Biogen” has the meaning set forth in the preamble. 1.13 “Biogen [*] Patent Right” means any Patent Right [*] that Covers or otherwise claims any Inventions developed or invented [*] [*] employees, agents, or independent contractors or any Persons contractually required to assign or license such Invention to [*] that [*], but expressly excluding [*]. 1.14 “Biogen [*] Know-How” means all Inventions developed or invented [*] employees, agents, or independent contractors or any Persons contractually required to assign or license such Inventions to [*] employees, agents, or independent contractors or any Persons contractually required to assign or license such Inventions to [*], in each case, that (a) [*] and (b) [*]. 1.15 “Biogen [*] Patent Rights” means all Patent Rights that Cover or otherwise claim Biogen [*] Know-How. 1.16 “Biogen [*] Technology” means Biogen [*] Know-How and Biogen [*] Patent Rights. 2 [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.